by James Edward Katz, M.D. | Nov 6, 2021 | Activism, Cancer, Charity, Outdoors, Public Health
Image courtesy Larry Li on Unsplash In 2012, oncologist Joshua Schiffman of the Huntsman Cancer Center encountered an elephant that would change his life. He had taken his children to the Hogle zoo in Salt Lake City, Utah. They had recently lost their Bernese Mountain...
by James Edward Katz, M.D. | Oct 30, 2021 | Cancer, Patient Care, Public Health
Why is it Not in Common Use? Cancer cells are hypermetabolic. They manufacture cholesterol at elevated rates to build new cell walls which enables their uncontrolled growth. In cell cultures, tumors deprived of cholesterol stop growing. Pravachol (pravastatin),...
by James Edward Katz, M.D. | Sep 21, 2019 | Activism, Boston, Cancer, Charity, Disease, Environment, Events, Healthy Aging, Outdoors, Public Health, Uncategorized
But the Elephant Gene Pool must Survive to Help UsMany of my relatives have died from cancer. I know everyone reading this has been touched by cancer. As a doctor for 40 years, I have seen countless cancer victims. I’m writing you about a unique opportunity to benefit...
by James Edward Katz, M.D. | Nov 9, 2013 | Age Management, Cancer, Disease, Health Supplements, Hormone Supplementation Therapy, Preventative Medicine
The WHI (now over a decade old) remains the largest randomly controlled trial of women’s hormonal medicines. The original publication of WHI identified increased risks of breast cancer, stroke, and cardiovascular disease associated with hormone therapy. These findings...
by James Edward Katz, M.D. | Nov 9, 2013 | Age Management, Aging, Cancer, Dementia, Disease, Medications, Preventative Medicine
The M. D. Anderson Hospital reported that Celebrex, an arthritis medication, reduced precancerous markers in smokers. Sloan-Kettering Hospital in New York confirmed similar results. Neither study was structured to see if Celebrex reduced lung tumors (that takes 10+...